Cross-sectional analysis of cardiovascular disease and risk factors in patients with spondyloarthritis: A real-life evidence from biostar nationwide registry
Göster/ Aç
Erişim
info:eu-repo/semantics/openAccessTarih
2023Yazar
Duruöz, Mehmet TuncayBodur, Hafize
Ataman, Şebnem
Gürer, Gülcan
Akgül, Özgür
Çay, H. F.
Çapkın, Erol
Altan İnceoğlu, Lale
Üst veri
Tüm öğe kaydını gösterKünye
Duruöz, M. T., Bodur, H., Ataman, Ş., Gürer, G., Akgül, Ö., Çay, H. F. ... Altan İnceoğlu, L. (2023). Cross-sectional analysis of cardiovascular disease and risk factors in patients with spondyloarthritis: A real-life evidence from biostar nationwide registry. European Congress of Rheumatology (EULAR) içinde (615-616. ss.). Milan, Italy, 31 May-03 June, 2023. https://dx.doi.org/10.1136/annrheumdis-2023-eular.1800Özet
Background: Association between spondyloarthritis and cardiovascular (CV) diseases is a complex issue with variable outcomes. Objectives: This study aimed to assess the prevalence rates of CV diseases and to analyze the impact of CV risk factors on CV disease in patients with spondyloarthritis. Methods: A multi-center cross-sectional study using BioSTAR (Biological and Targeted Synthetic Disease-Modifying Antirheumatic Drugs Registry) database was performed on patients with spondyloarthritis. Socio-demographic, laboratory and clinical, data were collected. Patients with and without major adverse cardiovascular events (MACE) were grouped as Group 1 and Group 2.The primary outcome was the prevalence rates of CV disease and CV risk factors in the overall group. The secondary outcome was the difference in socio-demographic and clinical characteristics between the groups and predictive risk factors for CV disease.
WoS Q Kategorisi
Q1Kaynak
European Congress of Rheumatology (EULAR)Cilt
82Sayı
Supplement: 1Bağlantı
https://dx.doi.org/10.1136/annrheumdis-2023-eular.1800https://hdl.handle.net/20.500.12511/12315
Koleksiyonlar
- Bildiri Koleksiyonu [64]
- WoS İndeksli Yayınlar Koleksiyonu [6433]